Financhill
Back

BeiGene Quote, Financials, Valuation and Earnings

BeiGene Price Quote

$176.57
+0.07 (+1.06%)
(Updated: December 21, 2024 at 5:17 AM ET)

BeiGene Key Stats

Sell
9
BeiGene (BGNE) is a Sell

Day range:
$175.80 - $179.25
52-week range:
$126.97 - $248.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.57
P/B ratio:
5.47%

Volume:
329.6K
Avg. volume:
429.1K
1-year change:
0.71%
Market cap:
$18.8B
Revenue:
$2.5B
EPS:
$-8.32

How Much Does BeiGene Make?

Data Unavailable

Is BeiGene Growing As A Company?

Data Unavailable

BeiGene Stock Price Performance

  • Did BeiGene Stock Go Up Last Month?
    BeiGene share price went down by -9.14% last month
  • Did BGNE's Share Price Rise Over The Last Year?
    BGNE share price rose by 0.71% over the past 1 year

What Is BeiGene 52-Week High & Low?

  • What Is BeiGene’s 52-Week High Share Price?
    BeiGene has traded as high as $248.16 over the past 52 weeks
  • What Is BeiGene’s 52-Week Low Share Price?
    BeiGene has traded as low as $126.97 over the past 52 weeks

BeiGene Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BeiGene?

Data Unavailable

Is BeiGene Cash Flow Positive?

Data Unavailable

BeiGene Return On Invested Capital

Data Unavailable

BeiGene Earnings Date & Stock Price

  • What Is BeiGene's Stock Price Today?
    A single share of BGNE can be purchased today for 176.50
  • What Is BeiGene’s Stock Symbol?
    BeiGene trades on the nasdaq under the ticker symbol: BGNE
  • When Is BeiGene’s Next Earnings Date?
    The next quarterly earnings date for BeiGene is scheduled on February 26, 2025
  • When Is BGNE's next ex-dividend date?
    BeiGene's next ex-dividend date is December 21, 2024
  • How To Buy BeiGene Stock?
    You can buy BeiGene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

BeiGene Competitors

  • Who Are BeiGene's Competitors?
    Below is a list of companies who compete with BeiGene or are related in some way:
    • Bristol-Myers Squibb Co (BMY)
    • Merck & Co Inc (MRK)
    • Dr Reddy's Laboratories Ltd (RDY)
    • Theravance Biopharma Inc (TBPH)
    • Zai Lab Ltd (ZLAB)

BeiGene Dividend Yield

Data Unavailable

BeiGene Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.24%
Revenue: 28.2% 1.76%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 280.92
Upside from Last Price: 59.16%

Major Shareholders

Data Unavailable